IVX Health, a national provider of infusion and injection therapy, will be opening a new South Austin location, according to ...

Accropeutics’ oral, selective TYK2/JAK1 inhibitor AC-201 has met the primary and key secondary endpoints in a Phase II ...

Let’s discuss four foods to avoid with psoriasis that may be affecting your skin, along with healthier substitutes.

Hair care expert on the smoothening treatment your scalp might secretly hate and the one that's right for your hair type.

For patients with psoriasis receiving biologic therapy, residual inflammation (RI), defined as increased inflammatory markers ...

A new study published in the journal of Acta Dermato Venerologica showed that menopause might have neutral to negative impact ...

MEDIA RELEASE Pyzchiva® first ustekinumab biosimilar in Europe commercially available in pre-filled pen (autoinjector), offering improved self-administration experience for better treatment adherence ...

For patients with genital psoriasis, apremilast improved genital Physician Global Assessment scores, itch, and quality of life with a tolerable safety profile.

Treatment with guselkumab among patients with psoriasis does not contribute to the risk for or progression of liver fibrosis.

Numerous autoimmune diseases are associated with the development of age-related macular degeneration (AMD), according to ...

Each ACELYRIN stockholder will receive 0.4814 shares of Alumis common stock for each share of ACELYRIN common stock owned. ACELYRIN common stock has ceased trading and will no longer be listed on the ...

Learn more about whether Alvotech or Arrowhead Pharmaceuticals, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.